Vaishali Pharma Ltd
VAIH.IN
$1.91
Closing
▼-1.82%
1D
▼-12.67%
YTD
Market cap
$20.44M
52 week high
$2.44
52 week low
$1.38
Volume
40,062
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$20.44M
Analysts' Rating
-
Price Target (Mean)
Unable to collect data for some field(s).
Total Analysts
0
P/E
30.83
Operating Margin
20.16%
Beta
0.62
Revenue Growth (Annual)
-14.73%
52 week high
$2.44
52 week low
$1.38
Div. Yield
%
EPS Annual Growth
0.00
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is engaged in dealing in pharmaceutical ingredient, pharmaceutical formulations, surgical products, herbal and nutraceutical products, veterinary supplements operating in domestic and export market. In domestic markets, it is engaged in contract manufacturing and trading of active pharmaceuticals ingredient’s (APIs) and supply of API’s for export captive consumption. In export markets, it is engaged in manufacturing and export of pharmaceutical formulations; manufacturing and export of surgical products; manufacturing and export of veterinary products; and manufacturing and export of herbal and nutraceuticals products. Its product categories include API, formulation brands, formulations, herbal, nutraceuticals, oncology, surgical and veterinary, among others. The Company markets approximately 400 products in domestic and APIs has a product portfolio of more than 1,000 products for the overseas market.
